Vivid Resourcing
Staffing Solutions across Europe and North America for STEM professionals | Vivid USA & Europe | Cisco Partner |
Chief Scientific Officer (CSO)
Company Type:
Early-stage Biotech | Focus: Genetic & Rare Diseases
About the Company:
Our client is a pioneering biotechnology company advancing transformative therapies for patients living with serious genetic and rare diseases. Backed by strong investors and a passionate leadership team, the company is translating cutting‑edge science into life‑changing treatments. With a robust pipeline of preclinical and early clinical programs, they are poised for rapid growth and seeking a visionary
Chief Scientific Officer (CSO)
to guide the scientific and strategic direction of the business.
Role Overview:
The CSO will be the scientific leader of the company—responsible for shaping and executing the R&D strategy, driving discovery and translational programs, and building a high‑performing scientific organization. This individual will work closely with the CEO, Board, and cross‑functional leaders to advance novel therapies from concept through development, while ensuring scientific excellence and innovation remain at the heart of the company.
Key Responsibilities
Define and lead the scientific vision and R&D strategy across genetic and rare disease programs.
Oversee discovery, translational research, and preclinical development activities.
Provide strategic input into clinical development planning and regulatory interactions.
Build, mentor, and inspire a world‑class scientific team with a culture of curiosity, collaboration, and excellence.
Evaluate emerging technologies, partnerships, and in‑licensing opportunities to strengthen the pipeline.
Represent the company’s science externally—with investors, partners, and the broader scientific community.
Partner closely with the CEO and executive team to guide strategic decision‑making and corporate growth.
Qualifications & Experience
PhD, MD, or MD/PhD in Molecular Biology, Genetics, or related discipline.
15+ years’ experience in biotech or pharma, with a strong track record of leading discovery and early development programs in genetic or rare diseases.
Proven ability to translate scientific innovation into therapeutic programs and move assets through IND‑enabling and early clinical stages.
Demonstrated leadership in building and scaling R&D organizations.
Strong understanding of gene therapy, RNA‑based therapeutics, or precision medicine approaches.
Excellent communication, leadership, and strategic thinking skills.
What’s on Offer
Opportunity to shape the direction of a cutting‑edge biotech at an inflection point of growth.
Collaborative and mission‑driven culture focused on transforming patient outcomes.
Competitive executive compensation and equity participation.
Please apply directly here or contact me on the following details if you have any questions:
+1 (980) 222 2267
#J-18808-Ljbffr
Company Type:
Early-stage Biotech | Focus: Genetic & Rare Diseases
About the Company:
Our client is a pioneering biotechnology company advancing transformative therapies for patients living with serious genetic and rare diseases. Backed by strong investors and a passionate leadership team, the company is translating cutting‑edge science into life‑changing treatments. With a robust pipeline of preclinical and early clinical programs, they are poised for rapid growth and seeking a visionary
Chief Scientific Officer (CSO)
to guide the scientific and strategic direction of the business.
Role Overview:
The CSO will be the scientific leader of the company—responsible for shaping and executing the R&D strategy, driving discovery and translational programs, and building a high‑performing scientific organization. This individual will work closely with the CEO, Board, and cross‑functional leaders to advance novel therapies from concept through development, while ensuring scientific excellence and innovation remain at the heart of the company.
Key Responsibilities
Define and lead the scientific vision and R&D strategy across genetic and rare disease programs.
Oversee discovery, translational research, and preclinical development activities.
Provide strategic input into clinical development planning and regulatory interactions.
Build, mentor, and inspire a world‑class scientific team with a culture of curiosity, collaboration, and excellence.
Evaluate emerging technologies, partnerships, and in‑licensing opportunities to strengthen the pipeline.
Represent the company’s science externally—with investors, partners, and the broader scientific community.
Partner closely with the CEO and executive team to guide strategic decision‑making and corporate growth.
Qualifications & Experience
PhD, MD, or MD/PhD in Molecular Biology, Genetics, or related discipline.
15+ years’ experience in biotech or pharma, with a strong track record of leading discovery and early development programs in genetic or rare diseases.
Proven ability to translate scientific innovation into therapeutic programs and move assets through IND‑enabling and early clinical stages.
Demonstrated leadership in building and scaling R&D organizations.
Strong understanding of gene therapy, RNA‑based therapeutics, or precision medicine approaches.
Excellent communication, leadership, and strategic thinking skills.
What’s on Offer
Opportunity to shape the direction of a cutting‑edge biotech at an inflection point of growth.
Collaborative and mission‑driven culture focused on transforming patient outcomes.
Competitive executive compensation and equity participation.
Please apply directly here or contact me on the following details if you have any questions:
+1 (980) 222 2267
#J-18808-Ljbffr